维普中文期刊产品整合服务
201篇 您的检索式:作者名="Doevendans"
    题名 作者 年代 出处 被引量
1Current status of assessment of fractional flow reserve显示文摘FANG Yi-min Grisana Grootenhuijs-Triyasut Pieter A. Doevendans Yolande Appelman 2009Chinese Medical Journal2009,,6:5
2MicroRNAs in the Human Heart: A Clue to Fetal Gene Reprogramming in Heart Failure显示文摘Thomas Thum Paolo Galuppo Christian Wolf Jan Fiedler Susanne Kneitz Linda W. van Laake Pieter A. Doevendans Christine L. Mummery Jürgen Borlak Axel Haverich Carina Gross Stefan Engelhardt Georg Ertl Johann Bauersachs 2007Circulation2007,,3:3
3Stem cells for cardiac repair: an introduction显示文摘Cardiovascular disease is a major cause of morbidity and mortality throughout the world. Most cardiovascular diseases, such as ischemic heart disease and cardiomyopathy, are associated with loss of functional cardiomyocytes. Unfortunately, the heart has a limited regenerative capacity and is not able to replace these cardiomyocytes once lost. In recent years, stem cells have been put forward as a potential source for cardiac regeneration. Pre-clinical studies that use stem cell-derived cardiac cells show promising results. The mechanisms,though, are not well understood, results have been variable, sometimes transient in the long term, and often without a mechanistic explanation.There are still severalmajor hurdles to be taken. Stem cell-derived cardiac cells should resemble original cardiac cell types and be able to integrate in the damaged heart. Integration requires administration of stem cell-derived cardiac cells at the right time using the right mode of delivery. Once delivered, transplanted cells need vascularization, electrophysiological coupling with the injured heart, and prevention of immunological rejection. Finally, stem cell therapy needs to be safe, reproducible, and affordable. In this review, we will give an introduction to the principles of stem cell based cardiac repair.Bastiaan C du Pr(e) Pieter A Doevendans Linda W van Laake 2013Journal of Geriatric Cardiology2013,10,2:2
4血压难以控制的高血压患者临时停用降压药的安全性分析显示文摘血压控制成功依赖于有效鉴别出继发性病因和发现高血压的发病因素。由于抗高血压药物可能会干扰诊断调查,在一些研究中可能会要求患者临时停药。然而,对于血压难以控制的高血压患者,临时停用抗高血压药物的安全性令人担忧。刘莉 叶鹏 Beeftink MM van der Sande NG Bots ML Doevendans PA Blankestijn PJ Visseren FL Voskuil M Spiering W 2017中华高血压杂志2017,25,4:2
5Mesenchymal stem cell-derived exosomes increase ATP levels, decrease oxidative stress and activate PI3K/Akt pathway to enhance myocardial viability and prevent adverse remodeling after myocardial ischemia/reperfusion injury显示文摘Fatih Arslan Ruenn Chai Lai Mirjam B. Smeets Lars Akeroyd Andre Choo Eissa N.E. Aguor Leo Timmers Harold V. van Rijen Pieter A. Doevendans Gerard Pasterkamp Sai Kiang Lim Dominique P. de Kleijn 2013Stem Cell Research2013,,3:2
6The severe cardiorenal syndrome : ' Guyton revisited' 显示文摘Bongartz LG Cramer M J Doevendans PA 2005Eur Heart J2005,26,1:1
7Differentiation of human embryonic stem cells to cardiomyocytes: role of cocuhure with visceral endodermlike cells 显示文摘Mummery C Ward-van Oostwaard D Doevendans P 2003Circulation2003,107,21:1
8显示文摘Mummery C Oostwaard DW Doevendans P 2003Circulation2003,107,:1
9“Thesevere cardiorenal syndrome: 'Guyton revisited”显示文摘BongartzLG Cramer MJ Doevendans PA 2005EurHeart J2005,26,1:1
10Human embryonic stem cell-derived cardiomyocytes and cardiac repair in rodents 显示文摘van Laake LW Passier R Doevendans PA 2008Circ Res2008,102,9:1
11Stem cell-derived angiogenic/vasculogenic ceils: possible therapies for tissue repair and tissue engineering 显示文摘ZWAGINGA JJ DOEVENDANS P 2003Clin Exp Pharmacol Physiol2003,30,:1
12The severe cardiorenal syndrome: guyton revisited显示文摘LBongartz LG Cramer M J Doevendans PA 2005Eur Heart J2005,26,11:1
13Vitamin D receptor: a new risk marker for clinical restenosis after percutaneous coronary intervention显示文摘Pascalle S Monraats Yue Fang Douwe Pons Nuno MM Pires Huibert AP Pols Aeilko H Zwinderman Moniek PM de Maat Pieter AF Doevendans Robbert J deWinter René A Tio Johannes Waltenberger Rune R Frants Paul HA Quax Arnoud van der Laarse Ernst E van der Wall Andr 2010Expert Opinion on Therapeutic Targets2010,,:1
14Isolation and expansion of resident cardiac progenitor cells显示文摘van Vliet P Sluijter JP Doevendans PA 2007Expert Rev Cardiovasc Ther2007,5,1:1
15Differentiation of human embryonic stem cells to cardio myocytes:role of co-culture with visceral endoderm-like cells显示文摘Mummery C Ward-van OD Doevendans P 0,,:1
16ABCA1 impacts athero-thrombotic risk and 10-year survival in a contemporary secondary prevention setting显示文摘Jakub J. Regieli Pieter A. Doevendans Diederick E. Grobbee Aeilko H. Zwinderman Yolanda van der Graaf John J.P. Kastelein J. Wouter Jukema 2011Atherosclerosis2011,,2:1
17The severe cardiorenal syndrome: 'Guyton revisited'显示文摘Bongartz LG Cramer MJ Doevendans PA 2005Eur Heart J2005,26,1:1
18A comparison of electrocardiographic changes during reperfusion of acute myocardial infarction by thrombolysis or percutaneous transluminal coronary angioplasty 显示文摘Wehrens XH Doevendans PA Ophuis TJ 2000Am Heart J2000,139,3:1
19Differentiation of human embryonic stem cells to cardiomyocytes:role of coculture with visceral endoderm-like cells显示文摘Mummery C Ward-van Oostwaard D Doevendans P 2003Circulation2003,107,:1
20Exenatide Reduces Infarct Size and Improves Cardiac Function in a Porcine Model of Ischemia and Reperfusion Injury显示文摘Leo Timmers José P.S. Henriques Dominique P.V. de Kleijn J. Hans DeVries Hans Kemperman Paul Steendijk Cees W.J. Verlaan Marjolein Kerver Jan J. Piek Pieter A. Doevendans Gerard Pasterkamp Imo E. Hoefer 2009Journal of the American College of Cardiology2009,,:1
返回顶部 每页显示:
共11页 首页 上一页 第1页 下一页 末页 /11 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费